In terms of mRNA expression, microtubule affinity regulating kinase 4 (MARK4) and Laminin Subunit Gamma 2 (LAMC2), with the highest dynamic weights in sample 66, may become potential high-efficiency targets for cancer treatment. Here, MARK4 is linked to cancer.